keyword
MENU ▼
Read by QxMD icon Read
search

Spontaneous bacterial peritonitis prophylaxis

keyword
https://www.readbyqxmd.com/read/27678356/spontaneous-fungal-peritonitis-epidemiology-current-evidence-and-future-prospective
#1
REVIEW
Marco Fiore, Sebastiano Leone
Spontaneous bacterial peritonitis is a complication of ascitic patients with end-stage liver disease (ESLD); spontaneous fungal peritonitis (SFP) is a complication of ESLD less known and described. ESLD is associated to immunodepression and the resulting increased susceptibility to infections. Recent perspectives of the management of the critically ill patient with ESLD do not specify the rate of isolation of fungi in critically ill patients, not even the antifungals used for the prophylaxis, neither optimal treatment...
September 14, 2016: World Journal of Gastroenterology: WJG
https://www.readbyqxmd.com/read/27512927/randomized-controlled-trial-of-rifaximin-versus-norfloxacin-for-secondary-prophylaxis-of-spontaneous-bacterial-peritonitis
#2
Asem Elfert, Lobna Abo Ali, Samah Soliman, Shimaa Ibrahim, Sherief Abd-Elsalam
BACKGROUND AND AIMS: Spontaneous bacterial peritonitis (SBP) is a serious complication of liver cirrhosis with a high recurrence rate and a marked increase in mortality. Norfloxacin is used widely for the secondary prophylaxis of SBP; however, its extensive long-term use has led to an increase in the incidence of quinolone-resistant and Gram-positive SBP. Rifaximin is a nonabsorbable broad-spectrum antibiotic and does not appear to promote emergence of resistance. The aim of this study was to compare the safety and efficacy of rifaximin versus norfloxacin for the secondary prevention of SBP in patients with liver cirrhosis and ascites...
December 2016: European Journal of Gastroenterology & Hepatology
https://www.readbyqxmd.com/read/27364035/the-impact-of-infection-by-multidrug-resistant-agents-in-patients-with-cirrhosis-a-multicenter-prospective-study
#3
Francesco Salerno, Mauro Borzio, Claudia Pedicino, Rosa Simonetti, Angelo Rossini, Sergio Boccia, Irene Cacciola, Andrew K Burroughs, Matteo Angelo Manini, Vincenzo La Mura, Paolo Angeli, Mauro Bernardi, Daniela Dalla Gasperina, Elena Dionigi, Clara Dibenedetto, Milena Arghittu
Bacterial strains resistant to antibiotics are a serious clinical challenge. We assessed the antibiotic susceptibility of bacteria isolated from infections in patients with cirrhosis by a multicentre investigation RESULTS: Three-hundred-thirteen culture-positive infections (173 community-acquired and 140 hospital-acquired) were identified in 308 patients. Urinary tract infections, spontaneous bacterial peritonitis and bacteremias were the most frequent. Quinolone-resistant Gram-negative isolates were 48%, 44% were ESBL producers and 9% carbapenem-resistant...
July 1, 2016: Liver International: Official Journal of the International Association for the Study of the Liver
https://www.readbyqxmd.com/read/27214392/selective-intestinal-decontamination-with-norfloxacin-enhances-a-regulatory-t-cell-mediated-inflammatory-control-mechanism-in-cirrhosis
#4
Oriol Juanola, Isabel Gómez-Hurtado, Pedro Zapater, Alba Moratalla, Esther Caparrós, Paula Piñero, José M González-Navajas, Paula Giménez, José Such, Rubén Francés
BACKGROUND&AIMS: Norfloxacin exerts immunomodulatory effects in cirrhosis beyond its bactericidal activity. We aimed at identifying the role of regulatory T (Treg) cells in the norfloxacin mechanism that compensates the inflammatory environment in cirrhosis. PATIENTS&METHODS: Consecutively admitted patients with cirrhosis and ascitic fluid (AF) with: spontaneous bacterial peritonitis (SBP), non-infected AF, and norfloxacin as secondary SBP prophylaxis (SID group)...
May 23, 2016: Liver International: Official Journal of the International Association for the Study of the Liver
https://www.readbyqxmd.com/read/27170392/current-management-of-the-complications-of-cirrhosis-and-portal-hypertension-variceal-hemorrhage-ascites-and-spontaneous-bacterial-peritonitis
#5
Guadalupe Garcia-Tsao
Cirrhosis is not a single entity but represents a disease progression across different prognostic stages, with the compensated and decompensated stages being the most important. Variceal hemorrhage (VH) and ascites are complications of cirrhosis that denote the presence of a decompensated stage. Spontaneous bacterial peritonitis (SBP) is a common bacterial infection unique to patients with cirrhosis that can precipitate the development of recurrent VH and hepatorenal syndrome (HRS), complications that denote the presence of a 'further decompensated' stage of cirrhosis...
2016: Digestive Diseases
https://www.readbyqxmd.com/read/26962397/bacterial-infections-in-cirrhosis-a-critical-review-and-practical-guidance
#6
REVIEW
Chalermrat Bunchorntavakul, Naichaya Chamroonkul, Disaya Chavalitdhamrong
Bacterial infection is common and accounts for major morbidity and mortality in cirrhosis. Patients with cirrhosis are immunocompromised and increased susceptibility to develop spontaneous bacterial infections, hospital-acquired infections, and a variety of infections from uncommon pathogens. Once infection develops, the excessive response of pro-inflammatory cytokines on a pre-existing hemodynamic dysfunction in cirrhosis further predispose the development of serious complications such as shock, acute-on-chronic liver failure, renal failure, and death...
February 28, 2016: World Journal of Hepatology
https://www.readbyqxmd.com/read/26660707/efficacy-and-safety-of-alternating-norfloxacin-and-rifaximin-as-primary-prophylaxis-for-spontaneous-bacterial-peritonitis-in-cirrhotic-ascites-a-prospective-randomized-open-label-comparative-multicenter-study
#7
M Assem, M Elsabaawy, M Abdelrashed, S Elemam, S Khodeer, W Hamed, A Abdelaziz, G El-Azab
BACKGROUND AND AIM: Primary prevention of spontaneous bacterial peritonitis (SBP) is an important strategy to reduce morbidity and mortality in cirrhotic patients with ascites. Efficacy and safety of alternating rifaximin and norfloxacin as primary prophylaxis is questionable. METHODS: Three hundred thirty-four cirrhotic patients with high SAAG (≥1.1) ascites, protein level in ascitic fluid less than 1.5 g/dL with advanced liver disease (Child-Pugh score >9 points with serum bilirubin level >3 mg/dL) or renal impairment (serum creatinine level >1...
March 2016: Hepatology International
https://www.readbyqxmd.com/read/26628837/management-patterns-of-hepatic-encephalopathy-a-nationwide-survey-in-india
#8
Praveen Sharma, Barjesh Chander Sharma
INTRODUCTION AND AIM: Hepatic encephalopathy (HE) is a common complication of cirrhosis. There is no standard practice for its management. This survey was done to determine the diagnostic and therapeutic practices of physicians treating patients with HE in patients with cirrhosis. MATERIAL AND METHOD: We designed a 21-item questionnaire, which was given to physicians working in academic and non-academic institutes and regularly treating patients with HE. RESULTS: Of 500 printed questionnaires, we received 451 questionnaires [323 (72%) general physicians and 128 (28%) gastroenterologists] from academic and non-academic institutes...
September 2015: Journal of Clinical and Experimental Hepatology
https://www.readbyqxmd.com/read/26528864/antibiotic-prophylaxis-in-cirrhosis-good-and-bad
#9
REVIEW
Javier Fernández, Puneeta Tandon, Jose Mensa, Guadalupe Garcia-Tsao
UNLABELLED: Patients with cirrhosis, particularly those with decompensated cirrhosis, are at increased risk of bacterial infections that may further precipitate other liver decompensations including acute-on-chronic liver failure. Infections constitute the main cause of death in patients with advanced cirrhosis, and strategies to prevent them are essential. The main current strategy is the use of prophylactic antibiotics targeted at specific subpopulations at high risk of infection: prior episode of spontaneous bacterial peritonitis, upper gastrointestinal bleeding, and low-protein ascites with associated poor liver function...
June 2016: Hepatology: Official Journal of the American Association for the Study of Liver Diseases
https://www.readbyqxmd.com/read/26407750/a-quality-improvement-initiative-reduces-30-day-rate-of-readmission-for-patients-with-cirrhosis
#10
Elliot B Tapper, Daniel Finkelstein, Murray A Mittleman, Gail Piatkowski, Matthew Chang, Michelle Lai
BACKGROUND & AIMS: Many hospitalized patients with cirrhosis are readmitted to the hospital within 30 days, particularly those with hepatic encephalopathy (HE). We performed a prospective study to assess the effects of a quality improvement protocol on readmission to a transplant center's liver unit within 30 days. METHODS: We studied the effects of a quality improvement program in 824 unique patients with decompensated cirrhosis or receiving liver transplants (mean Model for End-Stage Liver Disease score, 17...
May 2016: Clinical Gastroenterology and Hepatology
https://www.readbyqxmd.com/read/26358667/-spontaneous-bacterial-peritonitis-in-patients-with-cirrhosis
#11
Jean-Baptiste Nousbaum
Spontaneous bacterial peritonitis (SBP) is a severe complication occurring in patients with cirrhosis, and is associated with high mortality. Liver transplantation should be considered after a first episode of SBP. Gram-negative bacilli are the major cause of SBP, however there is an increasing trend of Gram-positive cocci related SBP. Management includes empirical antibiotic treatment and albumin infusion. The choice of antibiotics depends on the site of acquisition (community-acquired vs nosocomial or health-care associated infection) and local resistance profile, due to the emergence of drug-resistant bacteria...
December 2015: La Presse Médicale
https://www.readbyqxmd.com/read/26352909/update-in-hospital-medicine-evidence-you-should-know
#12
REVIEW
Kathleen M Finn, Jeffrey L Greenwald
BACKGROUND: The practice of hospital medicine is complex, and the number of clinical publications each year continues to grow. To maintain best practice it is necessary for hospitalists to stay abreast of the literature, but difficult to accomplish due to time. The annual Society of Hospital Medicine meeting offers a plenary session on Updates in Hospital Medicine. This article is a summary of those papers presented at the meeting. METHODS: We reviewed articles published between January 2014 and January 2015 in the leading medical journals, searching for papers with good methodological quality, the potential to change practice, and papers that are thought provoking...
December 2015: Journal of Hospital Medicine: An Official Publication of the Society of Hospital Medicine
https://www.readbyqxmd.com/read/26201326/bacterial-infections-in-cirrhosis
#13
Gregory J Botwin, Timothy R Morgan
Bacterial infections occur in 25-35 % of cirrhotics admitted to hospital. Health-care associated and hospital acquired (nosocomial) infections are the most common epidemiology, with community acquired infections less common (15-30 %). Spontaneous bacterial peritonitis and urinary infections are the most common sites, with spontaneous bacteremia, pneumonia, cellulitis and other sites being less common. The risk of infection is increased among subjects with more severe liver disease and an infection in the past 6 months...
September 2014: Hepatology International
https://www.readbyqxmd.com/read/26159277/treatment-of-spontaneous-bacterial-peritonitis
#14
Francesco Salerno, Vincenzo La Mura
Spontaneous bacterial peritonitis (SBP) is an infection of patients with cirrhosis and ascites. This peculiarity is due to the frequent intestinal translocation that allows bacteria to cross the intestinal barrier, colonizing the ascitic fluid. In cirrhosis, SBP is inferior only to urinary tract infections. It is prevalently sustained by Gram-negative bacteria such as Escherichia coli and Klebsiella. Risk factors for developing SBP are advanced age, refractory ascites, variceal bleeding, renal failure, low albumin levels (below 2...
2015: Digestive Diseases
https://www.readbyqxmd.com/read/25996499/the-spread-of-multi-drug-resistant-infections-is-leading-to-an-increase-in-the-empirical-antibiotic-treatment-failure-in-cirrhosis-a-prospective-survey
#15
Manuela Merli, Cristina Lucidi, Vincenza Di Gregorio, Marco Falcone, Valerio Giannelli, Barbara Lattanzi, Michela Giusto, Giancarlo Ceccarelli, Alessio Farcomeni, Oliviero Riggio, Mario Venditti
BACKGROUND: The spread of multi-resistant infections represents a continuously growing problem in cirrhosis, particularly in patients in contact with the healthcare environment. AIM: Our prospective study aimed to analyze epidemiology, prevalence and risk factors of multi-resistant infections, as well as the rate of failure of empirical antibiotic therapy in cirrhotic patients. METHODS: All consecutive cirrhotic patients hospitalized between 2008 and 2013 with a microbiologically-documented infection (MDI) were enrolled...
2015: PloS One
https://www.readbyqxmd.com/read/25887140/the-inca-trial-impact-of-nod2-genotype-guided-antibiotic-prevention-on-survival-in-patients-with-liver-cirrhosis-and-ascites-study-protocol-for-a-randomized-controlled-trial
#16
RANDOMIZED CONTROLLED TRIAL
Markus Casper, Martin Mengel, Christine Fuhrmann, Eva Herrmann, Beate Appenrodt, Peter Schiedermaier, Matthias Reichert, Tony Bruns, Cornelius Engelmann, Frank Grünhage, Frank Lammert
BACKGROUND: Patients with liver cirrhosis have a highly elevated risk of developing bacterial infections that significantly decrease survival rates. One of the most relevant infections is spontaneous bacterial peritonitis (SBP). Recently, NOD2 germline variants were found to be potential predictors of the development of infectious complications and mortality in patients with cirrhosis. The aim of the INCA (Impact of NOD2 genotype-guided antibiotic prevention on survival in patients with liver Cirrhosis and Ascites) trial is to investigate whether survival of this genetically defined high-risk group of patients with cirrhosis defined by the presence of NOD2 variants is improved by primary antibiotic prophylaxis of SBP...
2015: Trials
https://www.readbyqxmd.com/read/25848460/spontaneous-bacterial-peritonitis-the-clinical-challenge-of-a-leaky-gut-and-a-cirrhotic-liver
#17
REVIEW
Philipp Lutz, Hans Dieter Nischalke, Christian P Strassburg, Ulrich Spengler
Spontaneous bacterial peritonitis (SBP) is a frequent, life-threatening bacterial infection in patients with liver cirrhosis and ascites. Portal hypertension leads to increased bacterial translocation from the intestine. Failure to eliminate invading pathogens due to immune defects associated with advanced liver disease on the background of genetic predisposition may result in SBP. The efficacy of antibiotic treatment and prophylaxis has declined due to the spread of multi-resistant bacteria. Patients with nosocomial SBP and with prior antibiotic treatment are at a particularly high risk for infection with resistant bacteria...
March 27, 2015: World Journal of Hepatology
https://www.readbyqxmd.com/read/25835116/the-efficacy-and-the-immunomodulatory-effect-of-rifaximin-in-prophylaxis-of-spontaneous-bacterial-peritonitis-in-cirrhotic-egyptian-patients
#18
RANDOMIZED CONTROLLED TRIAL
Tarek Mostafa, Gamal Badra, Mahmoud Abdallah
BACKGROUND/AIMS: This study aimed to evaluate the efficacy and the immunomodulatory effect of rifaximin as another promising prophylactic therapy against spontaneous bacterial peritonitis (SBP) in cirrhotics. MATERIALS AND METHODS: Seventy cirrhotic patients with ascites were included in the study. Patients were divided into two groups in a randomized single-blind fashion. Group one (n=40) received rifaximin and group two (n=30) received norfloxacin (control group)...
March 2015: Turkish Journal of Gastroenterology: the Official Journal of Turkish Society of Gastroenterology
https://www.readbyqxmd.com/read/25819304/review-article-spontaneous-bacterial-peritonitis-bacteriology-diagnosis-treatment-risk-factors-and-prevention
#19
REVIEW
J B Dever, M Y Sheikh
BACKGROUND: Spontaneous bacterial peritonitis (SBP) is a severe and often fatal infection in patients with cirrhosis and ascites. AIM: To review the known and changing bacteriology, risk factors, ascitic fluid interpretation, steps in performing paracentesis, treatment, prophylaxis and evolving perspectives related to SBP. METHODS: Information was obtained from reviewing medical literature accessible on PubMed Central. The search term 'spontaneous bacterial peritonitis' was cross-referenced with 'bacteria', 'risk factors', 'ascites', 'paracentesis', 'ascitic fluid analysis', 'diagnosis', 'treatment', 'antibiotics', 'prophylaxis', 'liver transplantation' and 'nutrition'...
June 2015: Alimentary Pharmacology & Therapeutics
https://www.readbyqxmd.com/read/25813257/-spontaneous-bacterial-peritonitis
#20
REVIEW
Renáta Šenkeříková, Soňa Fraňková, Jan Šperl, Julius Špičák
Spontaneous bacterial peritonitis (SBP) represents a frequent and serious complication in patients with ascites in liver cirrhosis. Hospital mortality in patients with SBP reaches 10-20 %, so it is necessary to consider this diagnosis in every clinical decompensation of a cirrhotic patient, diagnose it early and treat it effectively. The clinical manifestation is nonspecific and variable, up to one third of patients might be asymptomatic. The diagnosis of SBP is based on the ascitic neutrophils count greater than 250 per mm3...
February 2015: Vnitr̆ní Lékar̆ství
keyword
keyword
21513
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"